BayWa Stock Punished by Markets as Auditor Dispute and Criminal Probes Overlay Restructuring Bid
Published on 06/25/2026 at 14:12 | Redaktion boerse-global.de
BayWa has managed to edge ahead of its own restructuring targets in the first quarter, but the market is not buying it. The Munich-based agricultural conglomerate’s shares have lost nearly half their value over the past twelve months, a reflection of mounting legal and regulatory troubles that are now testing investor patience more severely than the operational turnaround plan.
The stock closed at €11.10, down roughly 34% since the start of the year and almost 45% over a twelve-month horizon. That leaves the equity trading more than 53% below its 52-week high of €23.90, with a market capitalisation of around €700 million. Technical gauges paint a similarly bruising picture: the stock sits 14% below its 50-day moving average and more than 27% beneath the 200-day line. The relative strength index of 41.2 indicates no oversold bounce is imminent, while a 30-day annualised volatility reading of 74.5% points to sustained structural scepticism rather than panic.
PwC Ousted, KPMG Drafted In
The supervisory board is recommending that shareholders appoint KPMG as auditor for the 2026 financial statements, effectively ending PwC’s mandate. The trigger is a bitter falling-out: Germany’s auditor oversight authority, Apas, has launched a professional conduct proceeding against PwC, alleging it issued an unqualified audit opinion for 2023 without flagging existential risks. BayWa is now examining its own claims for damages against the former auditor. PwC still has to sign off on the 2025 results, but that process is running badly behind schedule. The consolidated financial statements are now not expected until 30 October 2026, the same date the company has set for publishing its 2025 group finance report. The complexity of write-downs and the unfinished restructuring plan are blamed for the delay.
Legal Front Opens on Multiple Flanks
The accounting dispute is just one element of a wider legal storm. In October 2025, the financial regulator BaFin rapped BayWa for failing to disclose material risks in its 2023 annual report – specifically a €1 billion credit line and refinancing risks tied to a €500 million bond. BayWa has lodged an appeal. Separately, the Munich public prosecutor is investigating former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and deliberately misrepresenting liquidity risks. Offices were searched in January; both men deny the allegations under the presumption of innocence.
Should investors sell immediately? Or is it worth buying BayWa?
Shareholder lawsuits are also piling up. The Tübingen-based law firm TILP is preparing a wave of compensation claims on behalf of investors who bought BayWa shares between January 2022 and January 2026, citing the same BaFin ruling. Already, Bavarian cooperative banks that extended a €220 million promissory note have written down 60% of its value in their 2024 accounts. Any new damage awards could squeeze the fragile recapitalisation plan further.
Restructuring Must Clear Three Hurdles by Autumn
The company is racing to close a €2.7 billion funding gap. A standstill agreement with its lenders runs until autumn 2026, and three conditions must be met by then: a signed-off 2025 annual audit, an extension of the standstill, and the completion of the sale of New Zealand subsidiary T&G Global. All three remain open.
The new restructuring blueprint is severe. Creditors are being asked to waive roughly €1 billion of debt. Around 1,300 jobs will be cut, and revenue is slated to shrink to €10 billion by 2028 as the group exits peripheral businesses. Portfolio disposals have already reduced debt by about €1.3 billion.
The first quarter of 2026 offered a sliver of operational comfort: adjusted EBITDA came in ahead of the restructuring plan’s internal targets, management said. But revenue slumped from €3.6 billion to €2.3 billion, partly by design as BayWa shed low-margin units such as the Cefetra Group.
BayWa at a turning point? This analysis reveals what investors need to know now.
Trust, Not Vision, Is Now the Commodity
The market’s deep discount reflects a loss of faith that cannot be fixed with a pretty story. Long touted as a hybrid of agriculture and renewable energy growth, BayWa now finds its credibility undercut at every turn – from customer uncertainty sparked by media coverage of its struggling renewables unit BayWa r.e., to a weak construction market and adverse weather. The agricultural trading division, the traditional anchor of trust, is being forced to prove that downsizing can be executed in a controlled manner.
No decisive verdict is expected before the fourth quarter of 2026, when both the bank agreement and the audited accounts are due. The annual general meeting – which must confirm replacements for departed supervisory board members – has yet to be scheduled. Until then, BayWa is not being priced for a recovery. It is being priced for the risk that the recovery never comes.
Ad
BayWa Stock: New Analysis - 25 June
Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
